In: International Immunology, 1996, vol. 8, no. 1, p. 57-63
|
In: International Immunology, 2008, vol. 21, no. 2, p. 123-135
|
In: International Immunology, 1991, vol. 3, no. 2, p. 127-134
|
In: Histopathology, 2011, vol. 59, no. 5, p. 965–974
Aims: Medullary breast cancer (MBC) is a biologically distinct subtype of breast cancer characterized by prominent lymphocytic infiltrates and a favourable clinical outcome. Tumour-infiltrating CD8+ effector T cells may contribute to the good prognosis of this type of cancer; however, certain subtypes of lymphocyte, such as FoxP3+ regulatory T cells (Tregs), can also suppress antitumour...
|